Your browser doesn't support javascript.
loading
Negative correlation between organ heteroplasmy, particularly hepatic heteroplasmy, and age at death revealed by post-mortem studies of m.3243A > G cases.
Yagi, Kunimasa; Okazaki, Satoko; Ohbatake, Azusa; Nakaya, Masako; Liu, Jianhui; Arite, Eiko; Miyamoto, Yukiko; Ito, Naoko; Nakano, Kaoru; Yamaaki, Naoto; Honoki, Hisae; Fujisaka, Shiho; Chujo, Daisuke; Tsunoda, Shin-Ichiro; Yanagimoto, Kunio; Nozue, Tsuyoshi; Yamada, Masayo; Ooe, Kotaro; Araki, Tsutomu; Nakashima, Akikatsu; Azami, Yasushi; Sodemoto, Yukio; Tadokoro, Kenichi; Nagano, Makoto; Noguchi, Tohru; Nohara, Atushi; Origasa, Hideki; Niida, Yo; Tada, Hayato.
Afiliação
  • Yagi K; Center for Clinical Genomics, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan; First Department of Internal Medicine, Toyama University, Toy
  • Okazaki S; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Ohbatake A; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Nakaya M; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Liu J; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan; First Department of Internal Medicine, Toyama University, Toyama 934-0194, Japan.
  • Arite E; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Miyamoto Y; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Ito N; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Nakano K; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Yamaaki N; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Honoki H; First Department of Internal Medicine, Toyama University, Toyama 934-0194, Japan.
  • Fujisaka S; First Department of Internal Medicine, Toyama University, Toyama 934-0194, Japan.
  • Chujo D; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan; First Department of Internal Medicine, Toyama University, Toyama 934-0194, Japan.
  • Tsunoda SI; Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, Yokohama 247-8581, Japan.
  • Yanagimoto K; Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, Yokohama 247-8581, Japan.
  • Nozue T; Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, Yokohama 247-8581, Japan.
  • Yamada M; Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, Yokohama 247-8581, Japan.
  • Ooe K; Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa 920-0353, Japan.
  • Araki T; Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa 920-0353, Japan.
  • Nakashima A; Department of Internal Medicine, Ishikawa Prefectural Central Hospital, Kanazawa 920-8530, Japan.
  • Azami Y; Kanazawa Johoku Hospital, Kanazawa 920-8616, Japan.
  • Sodemoto Y; Kanazawa Johoku Hospital, Kanazawa 920-8616, Japan.
  • Tadokoro K; Bio Medical Laboratory (BML), Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan.
  • Nagano M; Bio Medical Laboratory (BML), Inc., 1361-1 Matoba, Kawagoe, Saitama 350-1101, Japan.
  • Noguchi T; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
  • Nohara A; Department of Internal Medicine, Ishikawa Prefectural Central Hospital, Kanazawa 920-8530, Japan.
  • Origasa H; The Institute of Statistical Mathematics, Toyama University, Toyama 934-0194, Japan.
  • Niida Y; Center for Clinical Genomics, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan.
  • Tada H; Second Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan.
Mol Genet Metab ; 140(3): 107691, 2023 11.
Article em En | MEDLINE | ID: mdl-37660570
ABSTRACT
Mitochondrial DNA m.3243A > G mutation causes mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and its associated multi-organ disorders, including diabetes. To clarify associations between m.3243A > G organ heteroplasmy and clinical phenotypes, including the age at death, we combined genetic and pathological examinations from seven unreported and 36 literature cases of autopsied subjects. Clinical characteristics of subjects were as follows male, 13; female, 28; unknown, 2; the age at death, 36.9 ± 20.2 [4-82] years; BMI, 16.0 ± 2.9 [13.0-22.3]; diabetes, N = 21 (49%), diabetes onset age 38.6 ± 14.2 years; deafness, N = 27 (63%); stroke-like episodes (StLEp), N = 25 (58%); congestive heart failure (CHF), N = 15 (35%); CHF onset age, 51.3 ± 14.5 years. Causes of death (N = 32) were as follows cardiac, N = 13 (41%); infection, N = 8 (25%); StLEp, N = 4 (13%); gastrointestinal, N = 4 (13%); renal, N = 2 (6%); hepatic, N = 1 (2%). High and low heteroplasmies were confirmed in non-regenerative and regenerative organs, respectively. Heteroplasmy of the liver, spleen, leukocytes, and kidney for all subjects was significantly associated with the age at death. Furthermore, the age at death was related to juvenile-onset (any m.3243A > G-related symptoms appeared before 20) and stroke-like episodes. Multiple linear regression analysis with the age at death as an objective variable showed the significant contribution of liver heteroplasty and juvenile-onset to the age at death. m.3243A > G organ heteroplasmy levels, particularly hepatic heteroplasmy, are significantly associated with the age at death in deceased cases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome MELAS / Acidente Vascular Cerebral / Diabetes Mellitus Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Genet Metab Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome MELAS / Acidente Vascular Cerebral / Diabetes Mellitus Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Genet Metab Ano de publicação: 2023 Tipo de documento: Article